Medline Q3 Adj. EPS $0.44 Beats $0.35 Estimate, Sales $7.856B Beat $7.723B Estimate
Medline (NASDAQ:MDLN) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.35 by 25.71 percent. The company reported quarterly sales of $7.856 billion which beat the analyst
Medline made more money than experts predicted this quarter. When a company beats expectations, it shows strong business and smart management.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.